Photo from wikipedia
Improved transplant diagnostics and therapeutics have led to improved short-term allograft survival, yet have also resulted in increasing incidence of death with a functioning graft. The causes of death, including… Click to show full abstract
Improved transplant diagnostics and therapeutics have led to improved short-term allograft survival, yet have also resulted in increasing incidence of death with a functioning graft. The causes of death, including cancer and cardiovascular disease, most often reflect the biological age and comorbidities of the recipient. Cancer mortality in solid organ transplant recipients (SOTRs) is higher than in the general population and is now the second most common cause of death for recipients in developed nations (1). This article is protected by copyright. All rights reserved.
Journal Title: American Journal of Transplantation
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!